Evidence map›Paper›PMID 29282224›Full record

ArticleEMBO molecular medicine2018

Loss of RASGRP1 in humans impairs T-cell expansion leading to Epstein-Barr virus susceptibility.

Sarah Winter, Emmanuel Martin, David Boutboul, Christelle Lenoir, Sabah Boudjemaa, Arnaud Petit, Capucine Picard, Alain Fischer, Guy Leverger, Sylvain Latour

Open access · goldAbstract readCase Reports
In one paragraph

Article in EMBO molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Mechanistic Characterization ofFrontiers in immunology · 2019
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023
    Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. CellTrace™ Violet Flow Cytometric Assay to Assess Cell Proliferation.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  18. Human inborn errors of immunity to oncogenic viruses.Current opinion in immunology · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sarah WinterLaboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Paris, France.
Emmanuel MartinLaboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Paris, France.
David BoutboulLaboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Paris, France.
Christelle LenoirLaboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Paris, France.
Sabah BoudjemaaDepartment of Pathology, Armand Trousseau Hospital, Paris, France.
Arnaud PetitDepartment of Hematology and Pediatric Oncology, Armand Trousseau Hospital, Paris, France.
Capucine PicardLaboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Paris, France.
Alain FischerImagine Institut, University Paris Descartes Sorbonne Paris Cité, Paris, France.
Guy LevergerDepartment of Hematology and Pediatric Oncology, Armand Trousseau Hospital, Paris, France.
Sylvain LatourLaboratory of Lymphocyte Activation and Susceptibility to EBV infection, Inserm UMR 1163, Paris, France sylvain.latour@inserm.fr.ORCID 0000-0001-8238-4391
Inserm · FRSorbonne Université · FRHôpital Necker-Enfants Malades · FR

Funding

European Research Council 249816
6 · The paper itself

Abstract

Inherited CTPS1, CD27, and CD70 deficiencies in humans have revealed key factors of T-lymphocyte expansion, a critical prerequisite for an efficient immunity to Epstein-Barr virus (EBV) infection. RASGRP1 is a T-lymphocyte-specific nucleotide exchange factor known to activate the pathway of MAP kinases (MAPK). A deleterious homozygous mutation in

Indexed as

Cell ProliferationCells, CulturedChildDisease SusceptibilityDNA-Binding ProteinsEpstein-Barr Virus InfectionsGenetic Predisposition to DiseaseGuanine Nucleotide Exchange FactorsHodgkin DiseaseHumansImmunologic Deficiency SyndromesPedigreePrimary Immunodeficiency DiseasesDNA-Binding ProteinsGuanine Nucleotide Exchange FactorsRASGRP1 protein, humanHodgkin lymphomaimmunodeficiencylymphocytesusceptibility to Epstein–Barr virusT‐cell proliferation

Identifiers

PMID29282224
PMCPMC5801500
OpenAlexW2780710194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.